PDCD1 and cancer: They are regulators of the immune responses, critical for the prevention of excessive immune activation and the maintenance of self-tolerance.8 Their modulation has garnered scientific interest, especially as targets of cancer therapy.9 The pathway consisting of the Programmed cell Death protein-1 (PD-1) and its ligands (PDL-1 and 2) is one of the newer reported ICs.